Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
CPT: Pharmacometrics & Systems Pharmacology
|
June 19, 2025
A Combined Model-Based Meta-Analysis of Aggregated and Individual FEV1 Data From Randomized COPD Trials
Liang Yang, Carolina Llanos-Paez, Shuying Yang, et al.
Clinical Pharmacokinetics
|
October 26, 2018
Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients
Diansong Zhou, Jianguo Li, Khanh Bui, et al.
Clinical Pharmacology and Therapeutics
|
December 27, 2018
Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients
Diansong Zhou, Jianguo Li, Maria Learoyd, et al.
Current Alzheimer Research
|
March 26, 2013
The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H₃ receptor antagonist in patients with mild to moderate Alzheimer's disease: a preliminary investigation
Pradeep J Nathan, Rebecca Boardley, Nicola Scott, et al.
British Journal of Clinical Pharmacology
|
August 20, 2021
Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performance
Gael Cantet, Alienor Berges, Rhianna O'Sullivan, et al.
Pain Medicine (Malden, Mass.)
|
October 10, 2013
A phase 2a, randomized, crossover trial of gabapentin enacarbil for the treatment of postherpetic neuralgia in gabapentin inadequate responders
R Norman Harden, Roy Freeman, Michelle Rainka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2021
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study
Timothy A Yap, Matthew G Krebs, Sophie Postel-Vinay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2021
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer
Seung Tae Kim, Simon A Smith, Peter Mortimer, et al.
Plos One
|
May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial
Vincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
CPT: Pharmacometrics & Systems Pharmacology
|
June 19, 2025
A Combined Model-Based Meta-Analysis of Aggregated and Individual FEV1 Data From Randomized COPD Trials
Liang Yang, Carolina Llanos-Paez, Shuying Yang, et al.
Clinical Pharmacokinetics
|
October 26, 2018
Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients
Diansong Zhou, Jianguo Li, Khanh Bui, et al.
Clinical Pharmacology and Therapeutics
|
December 27, 2018
Efficacy and Safety Exposure-Response Analyses of Olaparib Capsule and Tablet Formulations in Oncology Patients
Diansong Zhou, Jianguo Li, Maria Learoyd, et al.
Current Alzheimer Research
|
March 26, 2013
The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H₃ receptor antagonist in patients with mild to moderate Alzheimer's disease: a preliminary investigation
Pradeep J Nathan, Rebecca Boardley, Nicola Scott, et al.
British Journal of Clinical Pharmacology
|
August 20, 2021
Concentration-QT modelling in early clinical oncology settings: Simulation evaluation of performance
Gael Cantet, Alienor Berges, Rhianna O'Sullivan, et al.
Pain Medicine (Malden, Mass.)
|
October 10, 2013
A phase 2a, randomized, crossover trial of gabapentin enacarbil for the treatment of postherpetic neuralgia in gabapentin inadequate responders
R Norman Harden, Roy Freeman, Michelle Rainka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2021
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study
Timothy A Yap, Matthew G Krebs, Sophie Postel-Vinay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2021
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer
Seung Tae Kim, Simon A Smith, Peter Mortimer, et al.
Plos One
|
May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial
Vincent Meininger, Pierre-François Pradat, Andrea Corse, et al.
Page
of 2